Ontology type: schema:ScholarlyArticle Open Access: True
2022-04-07
AUTHORSDavid S. H. Bell, Terri Jerkins
ABSTRACTWe present a case of prostate cancer (PC) developing in a hypogonadal patient with well-controlled type 1 diabetes. The purpose of reporting this case is to emphasize that regular prostate examinations and prostate-specific antigen (PSA) measurements should be preformed in the diabetic male, even though the incidence of PC is lower in this group of patients. In addition, these examinations and tests need to be preformed even in the hypogonadal patient with diabetes since the presence of a low serum testosterone (T) level does not preclude the development of PC. This is because the development of PC is not related to serum androgen levels but to the androgen levels within the prostate, and dihydrotestosterone (DHT) levels and not T levels within the prostate gland are responsible for the development of PC. In the hypogonadal male, intraprostatic DHT may be high since DHT can be formed from adrenal androgens, particularly androstenedione, through activation of 5α-reductase 2, which is the minority enzyme in the normal prostate but becomes the major enzyme in the formation and growth of PC. More... »
PAGES1115-1119
http://scigraph.springernature.com/pub.10.1007/s13300-022-01256-6
DOIhttp://dx.doi.org/10.1007/s13300-022-01256-6
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1146945143
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/35391594
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Southside Endocrinology, 1900 Crestwood Blvd, Suite 201, 35210, Irondale, AL, USA",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Southside Endocrinology, 1900 Crestwood Blvd, Suite 201, 35210, Irondale, AL, USA"
],
"type": "Organization"
},
"familyName": "Bell",
"givenName": "David S. H.",
"id": "sg:person.0723453627.37",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723453627.37"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Lipscomb University, Nashville, TN, USA",
"id": "http://www.grid.ac/institutes/grid.440609.f",
"name": [
"Lipscomb University, Nashville, TN, USA"
],
"type": "Organization"
},
"familyName": "Jerkins",
"givenName": "Terri",
"id": "sg:person.01122114507.11",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122114507.11"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/nrurol.2014.338",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1016002676",
"https://doi.org/10.1038/nrurol.2014.338"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11934-018-0812-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1105222975",
"https://doi.org/10.1007/s11934-018-0812-1"
],
"type": "CreativeWork"
}
],
"datePublished": "2022-04-07",
"datePublishedReg": "2022-04-07",
"description": "We present a case of prostate cancer (PC) developing in a hypogonadal patient with well-controlled type\u00a01 diabetes. The purpose of reporting this case is to emphasize that regular prostate examinations and prostate-specific antigen (PSA) measurements should be preformed in the diabetic male, even though the incidence of PC is lower in this group of patients. In addition, these examinations and tests need to be preformed even in the hypogonadal patient with diabetes since the presence of a low serum testosterone (T) level does not preclude the development of PC. This is because the development of PC is not related to serum androgen levels but to the androgen levels within the prostate, and dihydrotestosterone (DHT) levels and not T\u00a0levels within the prostate gland are responsible for the development of PC. In the hypogonadal male, intraprostatic DHT may be high since DHT can be formed from adrenal androgens, particularly androstenedione, through activation of 5\u03b1-reductase\u00a02, which is the minority enzyme in the normal prostate but becomes the major enzyme in the formation and growth of PC.",
"genre": "article",
"id": "sg:pub.10.1007/s13300-022-01256-6",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1044057",
"issn": [
"1869-6953",
"1869-6961"
],
"name": "Diabetes Therapy",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "5",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "13"
}
],
"keywords": [
"development of PCa",
"prostate cancer",
"hypogonadal patients",
"androgen levels",
"incidence of PCa",
"low serum testosterone levels",
"type 1 diabetic patients",
"prostate specific antigen measurements",
"growth of PCa",
"serum androgen levels",
"group of patients",
"serum testosterone levels",
"development of adenocarcinoma",
"diabetic males",
"hypogonadal males",
"adrenal androgens",
"testosterone deficiency",
"diabetic patients",
"dihydrotestosterone levels",
"prostate examination",
"testosterone levels",
"antigen measurement",
"normal prostate",
"prostate gland",
"patients",
"prostate",
"diabetes",
"major enzyme",
"males",
"examination",
"DHT",
"levels",
"adenocarcinoma",
"androgens",
"androstenedione",
"cancer",
"incidence",
"gland",
"cases",
"activation",
"deficiency",
"enzyme",
"group",
"development",
"test",
"presence",
"purpose",
"addition",
"types",
"growth",
"measurements",
"formation"
],
"name": "Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient",
"pagination": "1115-1119",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1146945143"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s13300-022-01256-6"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"35391594"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s13300-022-01256-6",
"https://app.dimensions.ai/details/publication/pub.1146945143"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T17:12",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_937.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s13300-022-01256-6"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01256-6'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01256-6'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01256-6'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13300-022-01256-6'
This table displays all metadata directly associated to this object as RDF triples.
131 TRIPLES
21 PREDICATES
79 URIs
69 LITERALS
7 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/s13300-022-01256-6 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1103 |
3 | ″ | schema:author | N1a1068f60623450aa271f7d2fffac426 |
4 | ″ | schema:citation | sg:pub.10.1007/s11934-018-0812-1 |
5 | ″ | ″ | sg:pub.10.1038/nrurol.2014.338 |
6 | ″ | schema:datePublished | 2022-04-07 |
7 | ″ | schema:datePublishedReg | 2022-04-07 |
8 | ″ | schema:description | We present a case of prostate cancer (PC) developing in a hypogonadal patient with well-controlled type 1 diabetes. The purpose of reporting this case is to emphasize that regular prostate examinations and prostate-specific antigen (PSA) measurements should be preformed in the diabetic male, even though the incidence of PC is lower in this group of patients. In addition, these examinations and tests need to be preformed even in the hypogonadal patient with diabetes since the presence of a low serum testosterone (T) level does not preclude the development of PC. This is because the development of PC is not related to serum androgen levels but to the androgen levels within the prostate, and dihydrotestosterone (DHT) levels and not T levels within the prostate gland are responsible for the development of PC. In the hypogonadal male, intraprostatic DHT may be high since DHT can be formed from adrenal androgens, particularly androstenedione, through activation of 5α-reductase 2, which is the minority enzyme in the normal prostate but becomes the major enzyme in the formation and growth of PC. |
9 | ″ | schema:genre | article |
10 | ″ | schema:isAccessibleForFree | true |
11 | ″ | schema:isPartOf | N130b2556a6d14927a1020c7fa245be82 |
12 | ″ | ″ | N6eab363c2b604648b18eb1f0e06c68c6 |
13 | ″ | ″ | sg:journal.1044057 |
14 | ″ | schema:keywords | DHT |
15 | ″ | ″ | activation |
16 | ″ | ″ | addition |
17 | ″ | ″ | adenocarcinoma |
18 | ″ | ″ | adrenal androgens |
19 | ″ | ″ | androgen levels |
20 | ″ | ″ | androgens |
21 | ″ | ″ | androstenedione |
22 | ″ | ″ | antigen measurement |
23 | ″ | ″ | cancer |
24 | ″ | ″ | cases |
25 | ″ | ″ | deficiency |
26 | ″ | ″ | development |
27 | ″ | ″ | development of PCa |
28 | ″ | ″ | development of adenocarcinoma |
29 | ″ | ″ | diabetes |
30 | ″ | ″ | diabetic males |
31 | ″ | ″ | diabetic patients |
32 | ″ | ″ | dihydrotestosterone levels |
33 | ″ | ″ | enzyme |
34 | ″ | ″ | examination |
35 | ″ | ″ | formation |
36 | ″ | ″ | gland |
37 | ″ | ″ | group |
38 | ″ | ″ | group of patients |
39 | ″ | ″ | growth |
40 | ″ | ″ | growth of PCa |
41 | ″ | ″ | hypogonadal males |
42 | ″ | ″ | hypogonadal patients |
43 | ″ | ″ | incidence |
44 | ″ | ″ | incidence of PCa |
45 | ″ | ″ | levels |
46 | ″ | ″ | low serum testosterone levels |
47 | ″ | ″ | major enzyme |
48 | ″ | ″ | males |
49 | ″ | ″ | measurements |
50 | ″ | ″ | normal prostate |
51 | ″ | ″ | patients |
52 | ″ | ″ | presence |
53 | ″ | ″ | prostate |
54 | ″ | ″ | prostate cancer |
55 | ″ | ″ | prostate examination |
56 | ″ | ″ | prostate gland |
57 | ″ | ″ | prostate specific antigen measurements |
58 | ″ | ″ | purpose |
59 | ″ | ″ | serum androgen levels |
60 | ″ | ″ | serum testosterone levels |
61 | ″ | ″ | test |
62 | ″ | ″ | testosterone deficiency |
63 | ″ | ″ | testosterone levels |
64 | ″ | ″ | type 1 diabetic patients |
65 | ″ | ″ | types |
66 | ″ | schema:name | Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient |
67 | ″ | schema:pagination | 1115-1119 |
68 | ″ | schema:productId | N426e5674ce4b4ab39f9ec012cd534954 |
69 | ″ | ″ | N7f9fcb0dd04f478eb974bcf9fa3bb256 |
70 | ″ | ″ | Na5d3921707d741ffb14d6a5310d87871 |
71 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1146945143 |
72 | ″ | ″ | https://doi.org/10.1007/s13300-022-01256-6 |
73 | ″ | schema:sdDatePublished | 2022-08-04T17:12 |
74 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
75 | ″ | schema:sdPublisher | N81cacb1ec21b41939b8721fa65bdcb0f |
76 | ″ | schema:url | https://doi.org/10.1007/s13300-022-01256-6 |
77 | ″ | sgo:license | sg:explorer/license/ |
78 | ″ | sgo:sdDataset | articles |
79 | ″ | rdf:type | schema:ScholarlyArticle |
80 | N130b2556a6d14927a1020c7fa245be82 | schema:volumeNumber | 13 |
81 | ″ | rdf:type | schema:PublicationVolume |
82 | N1a1068f60623450aa271f7d2fffac426 | rdf:first | sg:person.0723453627.37 |
83 | ″ | rdf:rest | N4ce63b26961d40d5969b781df31e16af |
84 | N426e5674ce4b4ab39f9ec012cd534954 | schema:name | pubmed_id |
85 | ″ | schema:value | 35391594 |
86 | ″ | rdf:type | schema:PropertyValue |
87 | N4ce63b26961d40d5969b781df31e16af | rdf:first | sg:person.01122114507.11 |
88 | ″ | rdf:rest | rdf:nil |
89 | N6eab363c2b604648b18eb1f0e06c68c6 | schema:issueNumber | 5 |
90 | ″ | rdf:type | schema:PublicationIssue |
91 | N7f9fcb0dd04f478eb974bcf9fa3bb256 | schema:name | doi |
92 | ″ | schema:value | 10.1007/s13300-022-01256-6 |
93 | ″ | rdf:type | schema:PropertyValue |
94 | N81cacb1ec21b41939b8721fa65bdcb0f | schema:name | Springer Nature - SN SciGraph project |
95 | ″ | rdf:type | schema:Organization |
96 | Na5d3921707d741ffb14d6a5310d87871 | schema:name | dimensions_id |
97 | ″ | schema:value | pub.1146945143 |
98 | ″ | rdf:type | schema:PropertyValue |
99 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
100 | ″ | schema:name | Medical and Health Sciences |
101 | ″ | rdf:type | schema:DefinedTerm |
102 | anzsrc-for:1103 | schema:inDefinedTermSet | anzsrc-for: |
103 | ″ | schema:name | Clinical Sciences |
104 | ″ | rdf:type | schema:DefinedTerm |
105 | sg:journal.1044057 | schema:issn | 1869-6953 |
106 | ″ | ″ | 1869-6961 |
107 | ″ | schema:name | Diabetes Therapy |
108 | ″ | schema:publisher | Springer Nature |
109 | ″ | rdf:type | schema:Periodical |
110 | sg:person.01122114507.11 | schema:affiliation | grid-institutes:grid.440609.f |
111 | ″ | schema:familyName | Jerkins |
112 | ″ | schema:givenName | Terri |
113 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122114507.11 |
114 | ″ | rdf:type | schema:Person |
115 | sg:person.0723453627.37 | schema:affiliation | grid-institutes:None |
116 | ″ | schema:familyName | Bell |
117 | ″ | schema:givenName | David S. H. |
118 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723453627.37 |
119 | ″ | rdf:type | schema:Person |
120 | sg:pub.10.1007/s11934-018-0812-1 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1105222975 |
121 | ″ | ″ | https://doi.org/10.1007/s11934-018-0812-1 |
122 | ″ | rdf:type | schema:CreativeWork |
123 | sg:pub.10.1038/nrurol.2014.338 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1016002676 |
124 | ″ | ″ | https://doi.org/10.1038/nrurol.2014.338 |
125 | ″ | rdf:type | schema:CreativeWork |
126 | grid-institutes:None | schema:alternateName | Southside Endocrinology, 1900 Crestwood Blvd, Suite 201, 35210, Irondale, AL, USA |
127 | ″ | schema:name | Southside Endocrinology, 1900 Crestwood Blvd, Suite 201, 35210, Irondale, AL, USA |
128 | ″ | rdf:type | schema:Organization |
129 | grid-institutes:grid.440609.f | schema:alternateName | Lipscomb University, Nashville, TN, USA |
130 | ″ | schema:name | Lipscomb University, Nashville, TN, USA |
131 | ″ | rdf:type | schema:Organization |